A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT06497556 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06497556
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-23
- Primary completion
- 2026-05-19
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.